| Literature DB >> 31849506 |
Karolina Dłużniak-Gołaska1, Mariusz Panczyk2, Agnieszka Szypowska3, Beata Sińska4, Dorota Szostak-Węgierek1.
Abstract
INTRODUCTION: Effectively conducted nutrition education is one of the key elements of the therapy of type 1 diabetes. The aim of the study was to compare the effectiveness of two methods of nutrition education.Entities:
Keywords: glycated hemoglobin; nutrition education; type 1 diabetes
Year: 2019 PMID: 31849506 PMCID: PMC6911330 DOI: 10.2147/DMSO.S229246
Source DB: PubMed Journal: Diabetes Metab Syndr Obes ISSN: 1178-7007 Impact factor: 3.168
Description of Individual Stages of the Study
| Stage of the Study | Study Plan | Group C | Group E |
|---|---|---|---|
| Stage I - baseline | The first consultation during hospitalization at the Department | Obtaining necessary sociodemographic and clinical data, key information about the treatment and control of glycemia + completing questionnaires | |
| Nutrition education in small groups | Informative methods | Informative + interactive methods | |
| After finishing hospitalization | – | The possibility of consulting a dietician by phone | |
| Stage II - after 3 months | A follow-up visit at Diabetology Clinic | Completing selected clinical data (body weight and height, blood pressure, HbA1c concentration) | |
| Stage III - after 6 months | A subsequent follow-up visit at Diabetology Clinic or hospitalization | Obtaining necessary data again + completing questionnaires | |
Abbreviations: Group C, control group; Group E, experimental group; HbA1c, glycated hemoglobin.
Figure 1Study flow diagram.
Baseline Characteristics of Patients
| Variable | All Patients (N = 151) | Group C (N = 81) | Group E (N = 70) | t | P-Valuea | |||
|---|---|---|---|---|---|---|---|---|
| M | SD | M | SD | M | SD | |||
| Age (years) | 13.72 | 2.19 | 13.49 | 1.99 | 13.99 | 2.40 | −1.378 | 0.170 |
| SDS-BMI (kg/m2) | 0.41 | 0.97 | 0.27 | 0.88 | 0.58 | 1.04 | −1.935 | 0.055 |
| WHtR (cm/cm) | 0.45 | 0.05 | 0.44 | 0.05 | 0.45 | 0.05 | −1.225 | 0.222 |
| HbA1c (%) | 8.17 | 1.84 | 7.89 | 1.68 | 8.51 | 1.97 | −2.086 | 0.039 |
| SDS-SBP (mmHg) | 1.09 | 1.09 | 1.05 | 1.16 | 1.13 | 1.01 | −0.432 | 0.666 |
| SDS-DBP (mmHg) | 1.84 | 1.13 | 1.87 | 1.11 | 1.80 | 1.16 | 0.352 | 0.725 |
| Duration of the disease (years) | 5.52 | 3.66 | 5.22 | 3.51 | 5.87 | 3.82 | −1.088 | 0.278 |
| Dose of insulin (U/kg BW/d) | 0.78 | 0.26 | 0.78 | 0.29 | 0.78 | 0.22 | −0.138 | 0.890 |
| CE value (CE/kg BW/d) | 0.39 | 0.15 | 0.40 | 0.13 | 0.37 | 0.16 | 0.892 | 0.374 |
| Index of healthy diet | 27.84 | 11.48 | 27.09 | 10.95 | 28.71 | 12.08 | −0.865 | 0.388 |
| Index of unhealthy diet | 22.46 | 11.26 | 22.71 | 11.01 | 22.16 | 11.62 | 0.298 | 0.766 |
| Total NKS | 22.22 | 6.63 | 21.52 | 6.50 | 23.03 | 6.74 | −1.399 | 0.164 |
| Healthful eating | 13.64 | 3.96 | 12.98 | 4.11 | 14.41 | 3.65 | −2.258 | 0.025 |
| Blood glucose response to food | 2.02 | 1.17 | 2.05 | 1.17 | 1.99 | 1.17 | 0.333 | 0.740 |
| Carbohydrate counting | 1.58 | 1.29 | 1.58 | 1.31 | 1.57 | 1.27 | 0.042 | 0.967 |
| Nutrition label reading | 4.98 | 1.88 | 4.91 | 1.89 | 5.06 | 1.89 | −0.466 | 0.642 |
Note: at-test.
Abbreviations: SDS-BMI, standard deviation score-body mass index; WHtR, waist to height ratio; HbA1c, glycated hemoglobin; SDS-SBP, standard deviation score-systolic blood pressure; SDS-DBP, standard deviation score-diastolic blood pressure; CE, carbohydrate exchanges; NKS, Nutrition Knowledge Survey; Group C, control group; Group E, experimental group.
Baseline Characteristics of Patients
| Variable | Variant | All Patients (N = 151) | Group C (N = 81) | Group E (N = 70) | P-Value | |||
|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | |||
| Sex | Male | 67 | 44.4 | 44 | 54.3 | 23 | 32.9 | 0.009a |
| Female | 84 | 55.6 | 37 | 45.7 | 47 | 67.1 | ||
| Place of residence | Village | 38 | 25.2 | 19 | 23.5 | 19 | 27.1 | 0.573b |
| Town | 59 | 39.1 | 30 | 37.0 | 29 | 41.4 | ||
| City | 54 | 35.8 | 32 | 39.5 | 22 | 31.4 | ||
| Parents’ education | Vocational | 16 | 10.6 | 8 | 9.9 | 8 | 11.4 | 0.818b |
| Secondary | 67 | 44.4 | 38 | 46.9 | 29 | 41.4 | ||
| Tertiary | 68 | 45.0 | 35 | 43.2 | 33 | 47.1 | ||
| Glycemic control | Glucometer | 142 | 94.0 | 78 | 96.3 | 64 | 91.4 | 0.304a |
| BGMS | 9 | 6.0 | 3 | 3.7 | 6 | 8.6 | ||
| CE calculation | No | 20 | 13.2 | 13 | 16.0 | 7 | 10.0 | 0.339a |
| Yes | 131 | 86.8 | 68 | 84.0 | 63 | 90.0 | ||
| Episodes of hypoglycemia | No/Several times a month | 101 | 66.9 | 58 | 71.6 | 43 | 61.4 | 0.226a |
| Several times a week/Every day | 50 | 33.1 | 23 | 28.4 | 27 | 38.6 | ||
| Episodes of hyperglycemia | No/Several times a month | 31 | 20.5 | 21 | 25.9 | 10 | 14.3 | 0.106a |
| Several times a week/Every day | 120 | 79.5 | 60 | 74.1 | 60 | 85.7 | ||
| Episodes of ketoacidosis | No | 150 | 99.3 | 80 | 98.8 | 70 | 100.0 | 1.000a |
| Yes | 1 | 0.7 | 1 | 1.2 | 0 | 0.0 | ||
| Physical activity | Low | 30 | 19.9 | 17 | 21.0 | 13 | 18.6 | 0.952b |
| Medium | 77 | 51.0 | 41 | 50.6 | 36 | 51.4 | ||
| High | 44 | 29.1 | 23 | 28.4 | 21 | 30.0 | ||
| BMI interpretation | Underweight/Normal | 117 | 77.5 | 64 | 79.0 | 53 | 75.7 | 0.698a |
| Overweight/Obese | 34 | 22.5 | 17 | 21.0 | 17 | 24.3 | ||
| WHtR interpretation | Norm | 130 | 86.1 | 70 | 86.4 | 60 | 85.7 | 1.000a |
| Above | 21 | 13.9 | 11 | 13.6 | 10 | 14.3 | ||
| BP interpretation | Norm | 56 | 39.2 | 28 | 36.8 | 28 | 41.8 | 0.608a |
| Above | 87 | 60.8 | 48 | 63.2 | 39 | 58.2 | ||
Notes: aFisher’s exact test, bFisher–Freeman–Halton exact test.
Abbreviations: BGMS, blood glucose monitoring system; CE, carbohydrate exchanges; BMI, body mass index; WHtR, waist to height ratio; BP, blood pressure; Group C, control group; Group E, experimental group.
Changes in Selected Clinical Parameters After 3 Months
| Variable | Group C (N = 81) | Group E (N = 70) | F | P-Valueb | ||||
|---|---|---|---|---|---|---|---|---|
| M | SD | Mean Change (95% CI)a | M | SD | Mean Change (95% CI)a | |||
| Baseline | 7.89 | 1.75 | 0.02 (−0.32; 0.36) | 8.46 | 1.90 | −0.47** (−0.77; −0.17) | 4.407 | 0.038 |
| 3 months | 7.91 | 1.93 | 7.99 | 1.19 | ||||
| Baseline | 0.25 | 0.89 | 0.09** (0.02; 0.15) | 0.53 | 1.02 | 0.16*** (0.09; 0.24) | 2.603 | 0.109 |
| 3 months | 0.33 | 0.93 | 0.69 | 1.00 | ||||
| Baseline | 1.16 | 1.14 | −0.88*** (−1.20; −0.55) | 1.05 | 1.03 | −0.89*** (−1.25; −0.53) | 0.004 | 0.953 |
| 3 months | 0.29 | 1.25 | 0.16 | 1.26 | ||||
| Baseline | 1.86 | 1.11 | −1.10*** (−1.51; −0.69) | 1.66 | 1.09 | −0.94*** (−1.34; −0.54) | 0.317 | 0.574 |
| 3 months | 0.76 | 1.22 | 0.72 | 1.12 | ||||
Notes: aMatched-pairs t-test; bMixed-design analysis of variance. **P<0.01, ***P<0.001. Differences in baseline mean values result from single missing data that was excluded from the change analysis.
Abbreviations: HbA1c, glycated hemoglobin; SDS-BMI, Standard Deviation Score-Body Mass Index; SDS-SBP, Standard Deviation Score-Systolic Blood Pressure; SDS-DBP, Standard Deviation Score-Diastolic Blood Pressure; Group C, control group; Group E, experimental group.
Changes Regarding the Occurrence of Hypertension and Overweight/Obesity After 3 Months
| Variable | N | % | P-Valuea | Odds Ratio (95% CI) | χ2 | P-Valueb |
|---|---|---|---|---|---|---|
| 1.530 | 0.216 | |||||
| Baseline | 35 | 61.4 | <0.001 | 0.16 (0.04; 0.46) | ||
| 3 months | 14 | 24.6 | ||||
| Baseline | 30 | 55.6 | 0.001 | 0.14 (0.03; 0.49) | ||
| 3 months | 12 | 22.2 | ||||
| 0.498 | 0.481 | |||||
| Baseline | 16 | 22.9 | 0.505 | 2.00 (0.43; 12.36) | ||
| 3 months | 19 | 27.1 | ||||
| Baseline | 14 | 23.0 | 0.221 | 5.00 (0.56; 236.49) | ||
| 3 months | 18 | 29.5 | ||||
Notes: aMcNemar’s test, bCochran–Mantel–Haenszel test. Differences in baseline values result from single missing data that was excluded from the change analysis.
Abbreviations: Group C, control group; Group E, experimental group.
Changes in Selected Clinical Parameters After 6 Months
| Variable | Group C (N = 81) | Group E (N = 70) | F | P-Valueb | ||||
|---|---|---|---|---|---|---|---|---|
| M | SD | Mean Change (95% CI)a | M | SD | Mean Change (95% CI)a | |||
| Baseline | 7.89 | 1.68 | 0.13 (−0.12; 0.37) | 8.51 | 1.97 | −0.14 (−0.36; 0.09) | 2.395 | 0.124 |
| 6 months | 8.01 | 1.65 | 8.37 | 1.49 | ||||
| Baseline | 0.27 | 0.88 | 0.14*** (0.06; 0.21) | 0.58 | 1.04 | 0.19*** (0.09; 0.28) | 0.809 | 0.370 |
| 6 months | 0.41 | 0.93 | 0.76 | 1.01 | ||||
| Baseline | 1.04 | 1.17 | −0.89*** (−1.21; −0.57) | 1.14 | 1.01 | −0.85*** (−1.21; −0.050) | 0.024 | 0.878 |
| 6 months | 0.15 | 1.41 | 0.29 | 1.17 | ||||
| Baseline | 1.83 | 1.10 | −1.16*** (−1.49; −0.82) | 1.77 | 1.17 | −0.99*** (−1.36; −0.61) | 0.451 | 0.503 |
| 6 months | 0.67 | 1.18 | 0.79 | 1.17 | ||||
| Baseline | 0.445 | 0.045 | 0.002 (−0.001; 0.004) | 0.454 | 0.047 | 0.003* (0.001; 0.006) | 0.881 | 0.349 |
| 6 months | 0.446 | 0.046 | 0.457 | 0.046 | ||||
| Baseline | 0.78 | 0.29 | 0.04 (−0.01; 0.10) | 0.78 | 0.22 | 0.07* (0.02; 0.13) | 0.579 | 0.448 |
| 6 months | 0.82 | 0.25 | 0.85 | 0.20 | ||||
| Baseline | 0.40 | 0.13 | −0.02 (−0.06; 0.02) | 0.38 | 0.16 | −0.05*** (−0.08; −0.02) | 1.804 | 0.182 |
| 6 months | 0.38 | 0.15 | 0.32 | 0.13 | ||||
Notes: aMatched-pairs t-test; bMixed-design analysis of variance. *P<0.05, ***P<0.001. Differences in baseline mean values result from single missing data that was excluded from the change analysis.
Abbreviations: HbA1c, glycated hemoglobin; SDS-BMI, standard deviation score-body mass index; SDS-SBP, standard deviation score-systolic blood pressure; SDS-DBP, standard deviation score-diastolic blood pressure; WHtR, waist to height ratio; CE, carbohydrate exchanges; Group C, control group; Group E, experimental group.
Changes Regarding the Occurrence of Hypertension and Overweight/Obesity After 6 Months
| Variable | N | % | P-Valuea | Odds Ratio (95% CI) | χ2 | P-Valueb |
|---|---|---|---|---|---|---|
| 1.010 | 0.315 | |||||
| Baseline | 43 | 62.3 | <0.001 | 0.14 (0.04; 0.41) | ||
| 6 months | 19 | 27.5 | ||||
| Baseline | 37 | 57.8 | <0.001 | 0.21 (0.07; 0.53) | ||
| 6 months | 15 | 23.4 | ||||
| 1.099 | 0.294 | |||||
| Baseline | 17 | 21.0 | 0.046 | 8.00 (1.07; 354.98) | ||
| 6 months | 24 | 29.6 | ||||
| Baseline | 17 | 24.3 | 0.371 | 4.00 (0.40; 196.99) | ||
| 6 months | 20 | 28.6 | ||||
Notes: aMcNemar’s test, bCochran–Mantel–Haenszel test. Differences in baseline values result from single missing data that was excluded from the change analysis.
Abbreviations: Group C, control group; Group E, experimental group.
Changes in the Scores Concerning Knowledge About Nutrition and Indices of the Quality of Diet After 6 Months
| Variable | Group C (N = 81) | Group E (N = 70) | F | P-Valueb | ||||
|---|---|---|---|---|---|---|---|---|
| M | SD | Mean Change (95% CI)a | M | SD | Mean Change (95% CI)a | |||
| Baseline | 27.09 | 10.95 | −2.98** (−5.10; −0.86) | 28.71 | 12.08 | −1.87 (−4.14; 0.39) | 0.507 | 0.478 |
| 6 months | 24.10 | 8.21 | 26.84 | 11.45 | ||||
| Baseline | 22.71 | 11.01 | −1.37 (−3.46; 0.72) | 22.16 | 11.62 | −1.75 (−4.09; 0.59) | 0.058 | 0.810 |
| 6 months | 21.34 | 9.90 | 20.41 | 10.84 | ||||
| Baseline | 21.52 | 6.50 | 3.00*** (1.73; 4.27) | 23.03 | 6.74 | 3.70*** (2.56; 4.84) | 0.650 | 0.422 |
| 6 months | 24.52 | 5.58 | 26.73 | 5.97 | ||||
| Baseline | 12.98 | 4.11 | 1.78*** (0.88; 2.68) | 14.41 | 3.65 | 1.83*** (1.09; 2.56) | 0.007 | 0.932 |
| 6 months | 14.75 | 3.57 | 16.24 | 3.72 | ||||
| Baseline | 2.05 | 1.17 | 0.41** (0.15; 0.66) | 1.99 | 1.17 | 0.80*** (0.52; 1.08) | 4.212 | 0.042 |
| 6 months | 2.46 | 1.01 | 2.79 | 0.98 | ||||
| Baseline | 1.58 | 1.31 | 0.43** (0.12; 0.74) | 1.57 | 1.27 | 0.61*** (0.29; 0.94) | 0.644 | 0.424 |
| 6 months | 2.01 | 1.26 | 2.19 | 1.40 | ||||
| Baseline | 4.91 | 1.89 | 0.38 (−0.04; 0.81) | 5.06 | 1.89 | 0.46* (0.09; 0.83) | 0.068 | 0.795 |
| 6 months | 5.30 | 1.62 | 5.51 | 1.39 | ||||
Notes: aMatched-pairs t-test; bMixed-design analysis of variance. *P<0.05, **P<0.01, ***P<0.001.
Abbreviations: NKS, Nutrition Knowledge Survey; Group C, control group; Group E, experimental group.